Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions.

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Abstract Text:

S Hatzopoulos,C Amoroso,C Aimoni,A Lo Monaco,M Govoni,A Martini,

Sjögren's syndrome (SS) is a cell-mediated immune disorder primarily affecting the exocrine glands and hearing loss may be the first otological manifestation of this autoimmune disease. In order to assess the degree of sensorineural hearing loss in SS, 22 female patients were examined by means of standard audiometric tests (pure-tone audiometry, acoustic reflexes and impedance testing) and using distortion product otoacoustic emissions (DPOAEs). The results indicated that only 36.3% of the patients had mild sensorineural hearing loss. Hearing level and distortion product threshold estimates were found to be significantly correlated. No relationship was found between the duration of the disease and the DPOAE and hearing threshold variables. The data suggest that SS may not directly cause sensorineural hearing loss.

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Publishing Authors By Initials

S Hatzopoulos,C Amoroso,C Aimoni,A Lo Monaco,M Govoni,A Martini,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Acta oto-laryngologica. Supplementum

VOLUME:

Page Numbers: 20-5

Journal Abbreviation:

ISSN: 0365-5237

DAY: 13

MONTH: 02

YEAR: 2002

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370355

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Keywords Mesh Terms:

KEYWORDS: Sjogren's Syndrome

MESH TERMS: complications

Chemical & Substance for Abstract: Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions.

AFFILIATION: Department of Audiology, University of Ferrara, Italy. sdh@dns.unife.it

Country: Norway

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Acta Otolaryngol Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions Related Publications

• 5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.
• Aberrant internal carotid artery in the middle ear: two case reports.
• Acute mastoiditis in children: the "Ferrara" experience.
• Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis.
• Antiphospholipid syndrome in pediatrics.
• Childhood systemic sclerosis.
• Cytogenetic and array CGH characterization of an intrachromosomal complex rearrangement of 4q in a patient with a 4q-phenotype.
• Differences in the Implementation of Diagnosis-Related Groups across Clinical Departments: A German Hospital Case Study.
• Does calcium supplementation reduce the risk of osteoporotic fracture and bone loss?
• Effects of parathyroidectomy on bone remodeling markers and vitamin D status in patients with chronic kidney disease-mineral and bone disorder.
• Ethanolic extract from Hemidesmus indicus (Linn) displays otoprotectant activities on organotypic cultures without interfering on gentamicin uptake.
• Floating dosage forms to prolong gastro-retention-The characterisation of calcium alginate beads.
• GABA A/Bz receptor subtypes as targets for selective drugs.
• Measuring the psychosocial consequences of hearing loss in a working adult population: focus on validity and reliability of the Italian translation of the hearing handicap inventory.
• Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood.
• Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia.
• Prophylactic failure of 1,500 units of tetanus antitoxin; a report of two cases.
• Recent views on the control of anterior pituitary function.
• Regulation of A(2A) adenosine receptor expression and functioning following permanent focal ischemia in rat brain.
• Sprue syndrome with secretory diarrhoea in a 42-year-old woman.
• Temporal bone brain herniation.
• The Paediatric Rheumatology International Trials Organization (PRINTO).
• The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/european League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: A prospective va
• [Factors of growth and metamorphosis of tadpoles. IV. Action of nicotinamide and coumarin.]
• [In Process Citation]
• [Liver cirrhosis after neosalversan therapy.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]